Mounjaro: tirzepatide for type 2 diabetes
Mounjaro is the brand name for injectable tirzepatide manufactured by Eli Lilly, approved for type 2 diabetes treatment. Like Zepbound, it acts on both GIP and GLP-1 receptors.
Brand notice: NoGuiltMeds is not affiliated with the manufacturers of these medications. Trademarks mentioned belong to their respective owners. Compounded products are not equivalent to FDA-approved brand-name products.
Frequently asked questions
Does Mounjaro help with weight loss?
Mounjaro contains tirzepatide, which has shown significant weight reduction in clinical studies, but it is approved for type 2 diabetes.
What is the difference between Mounjaro and Zepbound?
Both contain tirzepatide. Zepbound has specific approval for weight management; Mounjaro for type 2 diabetes.
You might also like
Online medical evaluation
Ready to start? The evaluation is free.
A licensed provider reviews every case. If you qualify, your plan can start from $99.
Start evaluation